Cargando…
Exploring the mechanism of JiGuCao capsule formula on treating hepatitis B virus infection via network pharmacology analysis and in vivo/vitro experiment verification
The JiGuCao capsule formula (JCF) has demonstrated promising curative effects in treating chronic hepatitis B (CHB) in clinical trials. Here, we aimed to investigate JCF’s function and mechanism in diseases related to the hepatitis B virus (HBV). We used mass spectrometry (MS) to identify the active...
Autores principales: | Cao, Xu, Zhang, Ningyi, Chen, Hening, Wang, Wei, Liang, Yijun, Zhang, Jiaxin, Liu, Ruijia, Li, Shuo, Yao, Yuhao, Jin, Qian, Guo, Ziwei, Chen, Yue, Gong, Yuanyuan, Li, Xiaoke, Zao, Xiaobin, Ye, Yong’an |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285482/ https://www.ncbi.nlm.nih.gov/pubmed/37361218 http://dx.doi.org/10.3389/fphar.2023.1159094 |
Ejemplares similares
-
The mechanism of TiaoGanYiPi formula for treating chronic hepatitis B by network pharmacology and molecular docking verification
por: Cao, Xu, et al.
Publicado: (2021) -
Uncovering the Pharmacological Mechanisms of Gexia-Zhuyu Formula (GXZY) in Treating Liver Cirrhosis by an Integrative Pharmacology Strategy
por: Cao, Xu, et al.
Publicado: (2022) -
Network pharmacology and in vitro experiments-based strategy to investigate the mechanisms of KangXianYiAi formula for hepatitis B virus-related hepatocellular carcinoma
por: Cao, Xu, et al.
Publicado: (2022) -
The host immune response of a discharged COVID-19 patient with twice reemergence of SARS-CoV-2: a case report
por: Zao, Xiaobin, et al.
Publicado: (2021) -
Quality Markers’ Discovery and Quality Evaluation of Jigucao Capsule Using UPLC-MS/MS Method
por: He, Yanmei, et al.
Publicado: (2023)